You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET fusion

Showing 1 - 25 of 1,629
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

NSCLC, Thyroid Tumors Trial (LOXO-260)

Temporarily not available
  • Carcinoma, Non-Small-Cell Lung
  • Thyroid Neoplasms
  • (no location specified)
Sep 20, 2022

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion

Recruiting
  • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Yongchang Zhang
    Mar 1, 2022

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Refractory Solid Tumors Trial in Seoul (sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

    Active, not recruiting
    Has Results
    • Solid Tumor
    • Medullary Thyroid Cancer
    • Guangzhou, Guangdong, China
    • +12 more
    May 9, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Aug 16, 2022

    Advanced Solid Tumor Trial in Chengdu (KL590586 Capsule)

    Enrolling by invitation
    • Advanced Solid Tumor
    • KL590586 Capsule
    • Chengdu, Sichuan, China
      Sichuan Kelun Botai Biopharmaceutical Co.
    Feb 23, 2022

    Pralsetinib to Best Available Therapy in RET-Fusion Positive

    Enrolling by invitation
    • RET-fusion Non Small Cell Lung Cancer
    • +16 more
      • New York, New York
      • +2 more
      Aug 9, 2021

      NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +3 more
      • Scottsdale, Arizona
      • +84 more
      Oct 10, 2022

      Advanced Solid Tumor Trial in Los Angeles (EP0031)

      Recruiting
      • Advanced Solid Tumor
      • Los Angeles, California
      • +3 more
      Dec 1, 2022

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

      Active, not recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +39 more
      • pralsetinib (BLU-667)
      • Phoenix, Arizona
      • +65 more
      Nov 10, 2022

      NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 17, 2022

      NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • Berazategui, Buenos Aires, Argentina
      • +195 more
      Jan 30, 2023

      Non Small Cell Lung Cancer, Ovarian Cancer, RET Gene Mutation Trial in New York (RXDX-105)

      Completed
      • Non Small Cell Lung Cancer
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center 1275 York Avenue
      Sep 30, 2020

      Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

      Recruiting
      • Cancer
      • +15 more
      • Data collection and quality of life questionnaire
      • Graz, Austria
      • +40 more
      Jul 27, 2021

      Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

      Recruiting
      • Non Small Cell Lung Cancer
      • +4 more
      • Irvine, California
      • +15 more
      Mar 9, 2022

      ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

      Terminated
      Has Results
      • ALK Fusion Protein Expression
      • +14 more
      • San Francisco, California
        University of California, San Francisco
      Jan 14, 2020

      Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

      Active, not recruiting
      • Advanced Nonhaematologic Malignancies
      • Philadelphia, Pennsylvania
      • +20 more
      Sep 23, 2022

      Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

      Recruiting
      • Non Small Cell Lung Cancer
      • immunity therapy
      • Changsha, Hunan, China
      • +1 more
      Feb 28, 2022

      NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

      Recruiting
      • Non-Small Cell Lung Cancer
      • San José, Costa Rica
      • +3 more
      Aug 4, 2022

      LMV-12 Combined With Osimertinib in NSCLC

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • LMV-12(HE003) and Osimertinib
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Oct 25, 2023